Breast cancer Archives

Breast cancer

Leading experts from centres of excellence have developed this suite of educational programmes to support your clinical decision-making.

CONNECTs

Our programmes

See All
Podcast
Experts knowledge share
E-learning
Video
Publication
Other

Oncology Endocrinology Pediatrics

Current opinions on how to identify and treat NTRK fusion positive cancer

Experts

Prof. David Hong, Prof. Ezra Cohen, Prof. Frédérique Penault-Llorca

Downloadable
Resources
5 MIN
Sep 2021

Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Bayer

Endocrinology Pediatrics Oncology

Key Publication Snapshot 5: TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors

Experts

Dr Luca Toschi

Downloadable
Resources
5 MIN
Sep 2021

Oncology Pediatrics Endocrinology

Learn about the patient journey through diagnosis and treatment of NTRK fusion positive cancer

Experts

Prof. Ulrik Lassen, Assoc. Prof. Caterina Marchiò

5 MIN
Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Pediatrics Endocrinology Oncology

NTRK CONNECT Update from ASCO 2020

Experts

Prof. Ezra Cohen

Downloadable
Resources
5 MIN
Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Oncology Endocrinology Pediatrics

Key Publication Snapshot 3 – Characterisation of adverse events caused by TRK inhibitor therapy

Experts

Prof. Ezra Cohen

Downloadable
Resources
5 MIN
Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Oncology Pediatrics Endocrinology

NTRK CONNECT Update from ESMO 2020

Experts

Prof. Viktor Grünwald

Downloadable
Resources
5 MIN
Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Pediatrics Oncology Endocrinology

Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from USCAP, ELCC and AACR 2021

Experts

Dr Fernando Santini

Downloadable
Resources
5 MIN
Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Endocrinology Pediatrics Oncology

Key Publication Snapshot 2 – Identifying patients with NTRK fusion cancer

Experts

Prof. Fernando López-Ríos, MD, PhD

Downloadable
Resources
5 MIN
Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Pediatrics Oncology Endocrinology

NTRK CONNECT Update from ESMO 2019

Experts

Assoc. Prof. Caterina Marchiò

Downloadable
Resources
5 MIN
Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Oncology Endocrinology Pediatrics

Key Publication Snapshot 1 – Larotrectinib and Entrectinib efficacy and safety profile in solid tumours

Experts

Prof. Andrea Sartore-Bianchi

Downloadable
Resources
5 MIN
Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Oncology Endocrinology Pediatrics

Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from ASCO and WCGIC 2021

Experts

Prof. Andrea Sartore-Bianchi

Downloadable
Resources
5 MIN
Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Pediatrics Oncology Endocrinology

NTRK gene fusions, TRK inhibitors and testing approaches BluePrint

Experts

Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, MD, PhD, Assoc. Prof. Gerald Prager

Downloadable
Resources
5 MIN
Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Oncology

An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition

Experts

Prof. Keiichi Fujiwara, Prof. Simon Boulton, Dr Shinji Ohno, Dr Rebecca Dent, Prof. Charlie Gourley

Downloadable
Resources
60 MIN
Sep 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Video

Oncology

Understand the MoA of PARP inhibitors and targeting DNA Damage Response (DDR)

Experts

Dr Robert L. Coleman, Prof. Simon Boulton

Downloadable
Resources
5 MIN
Sep 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Oncology

Moving from PARP Inhibition to Targeting DNA Repair and DDR in Cancer Therapy

Experts

Dr Judith Balmaña, Dr Rebecca Dent, Prof. Simon Boulton, Prof. Sibylle Loibl, Prof. Eric Pujade-Lauraine, Prof. Charlie Gourley, Dr Violeta Serra, Prof. Jonathan A. Ledermann

Downloadable
Resources
10 MIN
Sep 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Interactive e-learning

Oncology

The Role of PARP Inhibition in Clinical Practice

Experts

Prof. Jonathan A. Ledermann, Dr Rebecca Dent, Dr Robert L. Coleman, Prof. Eric Pujade-Lauraine

60 MIN
Sep 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Other

Oncology

The Role of DDR and PARP inhibition (PARPi) in Oncology – BluePrints

Experts

Dr Violeta Serra, Prof. Jonathan A. Ledermann, Prof. Eric Pujade-Lauraine, Prof. Simon Boulton, Dr Mark J. O'Connor, Prof. Charlie Gourley, Dr Judith Balmaña, Prof. Sibylle Loibl

Downloadable
Resources
MIN
Sep 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Oncology

PARP inhibition and DNA Damage Response (DDR)

This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types

Experts

Prof. Simon Boulton, Dr Violeta Serra, Dr Judith Balmaña, Prof. Charlie Gourley

30 MIN
Oct 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Oncology

Update From ASCO 2022 – Selected LBAs

COR2ED brings you an update on the late breaker plenary sessions from ASCO 2022

Experts

Dr Rebecca Dent, Prof. Chiara Cremolini, Asst. Prof. Hans Lee, Prof. Jonathan Trent

7 MIN
May 2022

Oncology

COR2ED at ESMO 2022

We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.

2 MIN
Sep 2022

Oncology

NTRK CONNECT update from WCLC, ECP and ESMO 2022

Experts

Dr Fernando Santini

Downloadable
Resources
5 MIN
Sep 2022

Educational programme supported by an Independent Educational Grant from Bayer

Oncology

Update From San Antonio Breast Cancer Symposium 2022

COR2ED presents an update on selected General Sessions from SABCS 2022

Experts

Dr Santiago Escrivá de Romaní

5 MIN
Dec 2022

Conference update

Episode

1

of 6

Oncology

Listen to Expert Insights on Late-Breaking Data from ASCO 2023

Episode 1: Non-Small-Cell Lung Cancer Update: ADAURA trial

Experts

Dr Mansoor Raza Mirza, Dr Paolo Tarantino, Prof. Alexey V Danilov, Prof. Mark Socinski, Prof. Evan Yu, Prof. Thomas Powles, Assoc. Prof. Gerald Prager

2 MIN
Jun 2023

Video

Episode

1

of 4

Oncology

New Oral Endocrine Therapy Options for Patients with Advanced or Metastatic ER+ Breast Cancer

Episode 1: Overview of Clinical Data of SERDs & Their Place in Treatment Landscape

Experts

Dr Sara Tolaney, Dr Aditya Bardia, Prof. Frédérique Penault-Llorca

Endorsed by

Downloadable
Resources
18 MIN
Jul 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology

Podcast

Episode

1

of 3

Oncology

Oral SERDs in ER+ breast cancer

Episode 1: Efficacy, safety and treatment landscape

Experts

Prof. Shaheenah Dawood, Assoc. Clinical Professor Rena Callahan

Endorsed by

MIN
Jul 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology

Interactive patient case

Episode

1

of 2

Oncology

Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer – Part 1

An interactive patient case video series from breast cancer specialists

Experts

Dr Elisa Agostinetto

Endorsed by

15 MIN
Sep 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology

Animated Video

Oncology

Navigating the ER+ Breast Cancer Journey: Oral SERDs and the Treatment Landscape

Follow a patient's breast cancer journey from diagnosis to treatment options

Experts

Prof. François-Clément Bidard

Endorsed by

Downloadable
Resources
7 MIN
Oct 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology.

Interactive patient case

Episode

2

of 2

Oncology

Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer – Part 2

An interactive patient case video series from breast cancer specialists

Experts

Prof. Valentina Guarneri

Endorsed by

15 MIN
Oct 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology

Tweetorial

Oncology

Tweetorial video: Navigating ER+ metastatic breast cancer

Explore a patient case from testing, diagnosis and treatment

Experts

Dr Paolo Tarantino

Endorsed by

9 MIN
Nov 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology

Video

Oncology

Actionable fusions in solid tumours

An overview of gene fusions, gold standard detection methods and treatment implications

Experts

Prof. Fernando López-Ríos, MD, PhD

Downloadable
Resources
3 MIN
Dec 2023

Educational programme supported by an Independent Educational Grant from Bayer.

Animated Video

Oncology

ER+ metastatic breast cancer: Elacestrant and beyond

Follow a patient's journey during and post-elacestrant treatment for ER+/HER2- metastatic breast cancer

Experts

Prof. Maria Vittoria Dieci

Endorsed by

Downloadable
Resources
5 MIN
Feb 2024

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology.

Conference update

Oncology

ER+ advanced breast cancer: Highlights from EBCC-14 satellite symposium

Medical experts discuss current and upcoming treatment strategies to use after CDK4/6 inhibitors in patients with ER+/HER2- advanced breast cancer

Experts

Prof. Valentina Guarneri, Prof. Matteo Lambertini, Prof. Federico Rojo

Downloadable
Resources
6 MIN
Mar 2024

Educational programme supported by an Independent Educational Grant from Menarini Stemline.

Tweetorial

Oncology

Tweetorial video: Treating ER+/HER2-low metastatic breast cancer, 2L and beyond

Journey through a patient case from testing and diagnosis to treatment and AE management

Experts

Dr Aditya Bardia

Endorsed by

11 MIN
Apr 2024

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology.

Conference update

Episode

2

of 4

Oncology

ASCO 2024 breast cancer highlights

How could the data impact clinical practice?

Experts

Prof. Shaheenah Dawood

3 MIN
Jun 2024

Conference update

Oncology

ESMO 2024: New data on GI, lung, HCC, breast and GU cancers

Renowned medical experts share their insights into new data presented at ESMO 2024

Downloadable
Resources
MIN
Sep 2024

Conference update

Oncology

Rezatapopt in TP53 Y220C mutated metastatic breast cancer: PYNNACLE phase 1/2 update

Exploring emerging treatment strategies presented at SABCS 2024

Experts

Prof. Frédérique Penault-Llorca, Dr Ecaterina E Dumbrava

Downloadable
Resources
5 MIN
Dec 2024

This programme has been sponsored by PMV Pharma.

Video

Oncology

Elacestrant in ER+/HER2- metastatic breast cancer

An expert overview of the EMERALD subgroup analysis

Experts

Dr Virginia Kaklamani

Downloadable
Resources
4 MIN
Dec 2024

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.

Video

Oncology

Recent advances in precision oncology and future implications

Two emerging and two established targets

Experts

Prof. David Hong

Downloadable
Resources
4 MIN
Dec 2024

Educational programme supported by an Independent Educational Grant from Bayer.

Video

Oncology

The evolving role of liquid biopsy in HR+/HER2- metastatic breast cancer

Exploring the impact of liquid biopsy in advanced breast cancer

Experts

Prof. Frédérique Penault-Llorca, Dr Aditya Bardia

Endorsed by

ICAN international cancer advocacy network

Downloadable
Resources
6 MIN
Jan 2025

Educational programme supported by an Independent Educational Grant from Thermo Fisher Scientific.

Conference update

Oncology

ESMO Virtual Plenary: Final OS results from the phase III TROPION-Breast01 trial

How will the latest Dato-DXd data impact treatment strategies for HR+/HER2− mBC?

Experts

Prof. François-Clément Bidard, Dr Barbara Pistilli

5 MIN
Feb 2025

Educational programme supported by an Independent Educational Grant from AstraZeneca

Conference update

Oncology

ER+ metastatic breast cancer: Highlights from the 13th APBCS Satellite Symposium

Medical experts discuss treatment strategies and sequencing after ET + CDK4/6i for ER+/HER2- metastatic breast cancer

Experts

Prof. Shaheenah Dawood, Prof. Heather McArthur, Prof. Javier Cortés, Prof. Frédérique Penault-Llorca

Downloadable
Resources
5 MIN
Feb 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.

Podcast

Oncology

ER+ metastatic breast cancer: Key insights on elacestrant from the latest EMERALD subgroup analyses

Experts' insights on treatment strategies in ER+ metastatic breast cancer settings

Experts

Dr Aditya Bardia, Dr Virginia Kaklamani

Downloadable
Resources
5 MIN
Mar 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.Video + Slide dec

Conference update

Oncology

Current and future treatment strategies for patients with ER+/HER2- early breast cancer

A closer look at the evolving treatment landscape

Experts

Prof. Michael Gnant, Prof. Giuseppe Curigliano

Downloadable
Resources
4 MIN
Mar 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.

Podcast

Oncology

HR+/HER2- metastatic breast cancer: Best practices in molecular testing and targeted therapy

Optimising precision medicine for improved patient outcomes

Experts

Dr Roberto Salgado, Assoc. Clinical Professor Rena Callahan

Endorsed by

Downloadable
Resources
26 MIN
Mar 2025

Educational programme supported by an Independent Educational Grant from Thermo Fisher Scientific.

Video

Oncology Patient Support

The patient perspective: Living with NSCLC driven by a rare alteration

What to know, what to expect, and where to find support

Endorsed by

5 MIN
Apr 2025

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim.

Animated Video

Oncology

Elacestrant in ER+/HER2- metastatic breast cancer with ESR1-mut tumors

An overview of the EMERALD subgroup analyses

Experts

Prof. Javier Cortés

Downloadable
Resources
8 MIN
Apr 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.

Animated Video

Oncology

ADCs in HR+/HER2- metastatic breast cancer

Optimising treatment strategies and AE management

Experts

Dr Barbara Pistilli

Endorsed by

Downloadable
Resources
MIN
May 2025

Educational programme supported by an Independent Educational Grant from AstraZeneca.

Symposium

Oncology

ER+/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium

Medical experts discuss treatment strategies and sequencing after ET + CDK4/6i for ER+/HER2- metastatic breast cancer

Experts

Prof. Wolfgang Janni, Prof. Sherko Kümmel, Prof. Michail Ignatiadis

Downloadable
Resources
5 MIN
May 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only

Conference update

Oncology

Highlights from ASCO 2025

Expert insights on the latest data

Experts

Prof. Mark Socinski, Dr Elizabeth Smyth, Dr Paolo Tarantino, Prof. Domenica Lorusso, Prof. Gerhardt Attard

Endorsed by

Downloadable
Resources
5 MIN
Jun 2025

The oncogene-addicted NSCLC supported through an Independent Educational Grant from Bayer with all other updates supported by COR2ED

Explore all programmes

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.